Cannara Biotech Inc. (TSXV: LOVE)
Canada
· Delayed Price · Currency is CAD 0.850
0.00 (0.00%)
Jan 21, 2025, 3:32 PM EST
Cannara Biotech Revenue
In the fiscal year ending August 31, 2024, Cannara Biotech had annual revenue of 81.75M CAD with 42.77% growth. Cannara Biotech had revenue of 23.04M in the quarter ending August 31, 2024, with 28.15% growth.
Revenue
81.75M
Revenue Growth
+42.77%
P/S Ratio
0.94
Revenue / Employee
n/a
Employees
n/a
Market Cap
76.52M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.51B |
| Curaleaf Holdings | 1.83B |
| WELL Health Technologies | 957.69M |
| dentalcorp Holdings | 1.51B |
| Trulieve Cannabis | 1.58B |
| Sienna Senior Living | 867.55M |
| Cronos Group | 150.26M |
| Extendicare | 1.42B |